SNDX
Syndax Pharmaceuticals, Inc. · Healthcare
CEO Michael A Metzger sold $153K of Syndax Pharmaceuticals, Inc.
Sold$152,835
$20.62Price
7,412Shares
−1%Stake
What SNDX did after the filing
- The stock from Fri, Feb 6 close, $21.01
- +14.7%
- S&P 500, same days
- −5.1%
Measured over 30 trading days, to the Mar 23 close.
Traded Fri, Feb 6. Filed Fri, Feb 6, 12:54 PM ET, during the session. Returns use the Feb 6 close and the Mar 23 close. Not investment advice.